This case study is the first instance I've [Geo] seen describing the development of an anti-emicizumab antibody that appears to suppress hemophilia A therapy: /sites/default/files/anti-emicizumab_kaneda_jth_2021.pdf
Posts - Bleeding Disorders
Sep 3, 2021 8:31am
Our August 2021 Quick Question, which asks, "Which factor deficiency causes the smallest risk of bleeding?" drew a respectable 48 votes. Answers:
Aug 19, 2021 4:57pm
The Precision BioLogic Inc. and the Affinity Biologicals, Inc. research team presented a poster comparing chromogenic versus clot-based factor VIII assays measuring pegylated factor VIII therapeutic concentrate at
Aug 19, 2021 4:52pm
At the July 17–21, 2021 meeting of the International Society on Thrombosis and Haemostasis, the Precision BioLogic Inc. and the Affinity Biologicals, Inc. research team presented a poster that demonstrates how inactivated factor VIII reagent preparations that are employed for factor VIII activity assays and inhibitor assays may contain factor VIII that is detectable by immunoassay, albeit physiologically inactive.